{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:23:44Z","timestamp":1771676624063,"version":"3.50.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The incidence and mortality of lung cancer rank first among malignant tumors, and its long treatment cycle will bring serious economic burdens to lung cancer patients and their families. There are few studies on the prognosis of lung cancer and insurance policies. This article explores the relationship between the lung cancer-specific death and public health insurance, self-paying rate, and the joint effect of public health insurance and self-paying rate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>A prospective longitudinal cohort study was conducted in Chongqing, China from 2013 to 2019. The selected subjects were patients with C33\u2013C34 coded according to the tenth edition of the International Classification of Diseases (ICD-10), aged 20 years or older. We conduct a subgroup analysis based on public health insurance types and self-paying rates. After following the inclusion and exclusion criteria, the <jats:italic>chi-square<\/jats:italic> test was used to describe the demographic and clinical characteristics of patients with different insurance types and different self-paying rates. Multivariate logistic regression was used to analyze the relationship between patients with different insurance types, self-paying rates, and lung cancer treatment methods. Finally, the Cox proportional hazard model and the competitive risk model are used to calculate the cumulative hazard ratio of all-cause death and lung cancer-specific death for different insurance types and different self-paying rate groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 12,464 patients with lung cancer were included in this study. During the follow-up period (median 13 months, interquartile range 5.6\u201325.2 months), 5,803 deaths were observed, of which 3,781 died of lung cancer. Compared with patients who received urban resident-based basic medical insurance (URBMI), patients who received urban employee-based basic medical insurance (UEBMI) had a 38.1% higher risk of lung cancer-specific death (Hazard Ratios (HRs) = 1.381, 95% confidence interval (CI): 1.293\u20131.476, <jats:italic>P<\/jats:italic> &amp;lt; 0.005), Compared with patients with insufficient self-paying rate, patients with a higher self-paying rate had a 40.2% lower risk of lung cancer-specific death (HRs = 0.598, 95% CI: 0.557\u20130.643, <jats:italic>P<\/jats:italic> &amp;lt; 0.005). Every 10% increase in self-paying rate of URBMI reduces the risk of lung cancer-specific death by 17.6%, while every 10% increase in self-paying rate of UEBMI reduces the risk of lung cancer-specific death by 18.0%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The National Medical Security Administration should, under the condition of limited medical insurance funds, try to include the original self-paid anti-tumor drugs into the national medical insurance coverage. This can not only reduce the mortality rate of lung cancer patients, but also reduce the family burden of lung cancer patients. On the other hand, high-risk groups should increase their awareness of lung cancer screening and actively participate in the national cancer screening project led by the state.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2022.842844","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T06:38:15Z","timestamp":1651214295000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Lung Cancer-Specific Mortality Risk and Public Health Insurance: A Prospective Cohort Study in Chongqing, Southwest China"],"prefix":"10.3389","volume":"10","author":[{"given":"Yuqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haike","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guixue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anlong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1378\/chest.11-2948","article-title":"Lung cancer in China: challenges and interventions","volume":"143","author":"She","year":"2013","journal-title":"Chest."},{"key":"B2","doi-asserted-by":"publisher","first-page":"721","DOI":"10.19401\/j.cnki.1007-3639.2020.10.001","article-title":"The global prevalence and prevention progress of lung cancer China","volume":"30","author":"Xiao","year":"2020","journal-title":"Oncology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1759-7714.12916","article-title":"Epidemiology of lung cancer in China","volume":"10","author":"Cao","year":"2019","journal-title":"Thorac Cancer."},{"key":"B4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/1759-7714.12286","article-title":"Lung cancer incidence and mortality in China, 2011","volume":"7","author":"Zheng","year":"2016","journal-title":"Thorac Cancer."},{"key":"B6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3760\/cma.j.issn.0253-3766.2019.01.008","article-title":"Report of cancer epidemiology in China, 2015","volume":"41","author":"Zheng","year":"2019","journal-title":"Chinese J Oncology"},{"key":"B7","first-page":"331","article-title":"Trend of the incidence and mortality of lung cancer in Chongqing municipality from 2010 to 2017","volume":"27","author":"Ding","year":"2020","journal-title":"China Cancer."},{"key":"B8","first-page":"693","article-title":"Analysis of the relationship between 3.0TMR and PET\/CT imaging features and different pathological features of lung cancer","author":"Liang","year":"2020","journal-title":"Chinese J Lung Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e48323","DOI":"10.1371\/journal.pone.0048323","article-title":"The cost of treating advanced non-small cell lung cancer: estimates from the Chinese experience","volume":"7","author":"Zeng","year":"2012","journal-title":"PLoS ONE"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph14030308","article-title":"Economic burden for lung cancer survivors in urban China","volume":"14","author":"Zhang","year":"2017","journal-title":"Int J Environ Res Public Health."},{"key":"B11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3969\/j.issn.1003-0743.2004.01.022","article-title":"Discussion on the evaluation method of personal medical burden under the medical insurance system","volume":"23","author":"Guan","year":"2004","journal-title":"Chinese Health Eco"},{"key":"B12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.16304\/j.cnki.11-3952\/f.2018.05.012","article-title":"An analysis on the influencing factors of medical insurance choice behavior of Chinese urban residents:based on the binary unit probability model","volume":"13","author":"Zhu","year":"2018","journal-title":"Macroeconomics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6963-11-67","article-title":"The effect of health insurance reform on the number of cataract surgeries in Chongqing, China","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Health Serv Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1002\/hec.1525","article-title":"Economic analysis of China's health care system: turning a new page","volume":"18","author":"Yip","year":"2010","journal-title":"Health Econ."},{"key":"B15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.11847\/zgggws1127074","article-title":"Demand and utilization of medical service, medical expenses and family economic risks among chronic disease patients with different medical insurance systems in China","volume":"37","author":"Shan","year":"2021","journal-title":"Chinese J Public Health"},{"key":"B16","first-page":"862","article-title":"Accessibility of high-cost anti-cancer medicines in China","volume":"17","author":"Zhou","year":"2017","journal-title":"Chinese J Evidence-Based Med."},{"key":"B17","volume-title":"Feasibility Research of the Ixabepilone Project","author":"Zhang","year":"2018"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjgh-2021-006196","article-title":"The The impacts of government reimbursement negotiation on targeted anticancer medication price volume and spending in China","volume":"6","author":"Zhang","year":"2021","journal-title":"BMJ Glob Health."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph16193728","article-title":"Availability, price and affordability of anticancer medicines: evidence from two cross-sectional surveys in the Jiangsu province, China","volume":"16","author":"Zhu","year":"2019","journal-title":"Int J Environ Res Public Health."},{"key":"B20","article-title":"Study on Economic Burden of Lung Cancer Patients and the Effect of Medical Insurance Policies in Nanchang","author":"Wu","year":"2016"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1002\/cncr.29584","article-title":"Prevention and management of lung cancer in China","volume":"121","author":"Hong","year":"2015","journal-title":"Cancer."},{"key":"B22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/CCO.0000000000000703","article-title":"Zhou C. Lung cancer in China: current and prospect","volume":"33","author":"Wu","year":"2021","journal-title":"Curr Opin Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12962-021-00306-3","article-title":"Medical expenditure for lung cancer in China: a multicenter, hospital-based retrospective survey","volume":"19","author":"Zhang","year":"2021","journal-title":"Cost Eff Resour Alloc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3760\/cma.j.issn.0253-9624.2017.02.002","article-title":"Dai, M. Health economic evaluation of cancer screening in China","volume":"51","author":"Shi","year":"2017","journal-title":"Chinese J Preventive Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2018-054767","article-title":"Economic burden of lung cancer attributable to smoking in China in 2015","author":"Shi","year":"2018","journal-title":"The 19th National Tobacco Control Symposium of China Tobacco Control Association"},{"key":"B26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1164\/rccm.201910-1926OC","article-title":"Respirable crystalline silica exposure, smoking, and lung cancer subtype risks a pooled analysis of case-control studies","volume":"202","author":"Ge","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00420-020-01537-2","article-title":"Estimating the burden of lung cancer in Canada attributed to occupational radon exposure using a novel exposure assessment method","volume":"93","author":"Ge","year":"2020","journal-title":"Int Arch Occup Environ Health"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-77291-9","article-title":"Characteristics of asbestos fibers in lung tissue from occupational and environmental asbestos exposure of lung cancer patients in Busan, Korea","volume":"10","author":"Jung","year":"2020","journal-title":"Sci Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1158\/1055-9965.EPI-19-0887","article-title":"Whole exome sequencing of highly aggregated lung cancer families reveals linked Loci for increased cancer risk on chromosomes 12q, 7p and 4q[J]","volume":"29","author":"Musolf A","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djh180","article-title":"Are women more susceptible to lung cancer?","volume":"11","author":"Blot","year":"2004","journal-title":"J Natl Cancer Inst."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.842844\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T06:38:52Z","timestamp":1651214332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.842844\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":30,"alternative-id":["10.3389\/fpubh.2022.842844"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.842844","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"article-number":"842844"}}